國家衛生研究院 NHRI:Item 3990099045/11921
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 914955      在线人数 : 1422
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11921


    题名: Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005-2013: A population-based study
    作者: Huang, CW;Chiu, YW;Chen, PJ;Yu, NW;Tsai, HJ;Chang, CM
    贡献者: Institute of Population Health Sciences
    摘要: AIM: Antipsychotics off-label use is common in clinical practice but information is limited to reveal the trends of antipsychotic use in specific mental disorder in Taiwan. This study aimed to examine the trends and associated factors of antipsychotic use among outpatients with anxiety disorders in Taiwan during 2005-2013. METHODS: We assessed the annual prescriptions of antipsychotic use in 9 consecutive years (2005-2013) using the National Health Insurance Research Database among adults (aged >/=18 years) with anxiety disorders in outpatient visits in Taiwan. We applied logistic regression to examine the trends and associated factors of antipsychotic use. RESULTS: The proportion of antipsychotic medication use for anxiety disorder increased from 8.4% in 2005 to 9.1% in 2013. First-generation antipsychotics (FGAs) use is more than that of second-generation antipsychotics (SGAs) in patients with anxiety disorder through the 9-year period. Sulpiride and flupentixol were the two-most common FGAs in the treatment of anxiety disorder. Patients with specific anxiety disorder (traumatic stress disorder, panic disorder/agoraphobia, generalized anxiety disorder, and obsessive compulsive disorder), female gender, younger adult (age <65 years), comorbidity with major depression or minor depression, antidepressants concurrent use and visits to psychiatrists, medical centers and primary care were significantly tended to prescribe antipsychotics. CONCLUSION: Antipsychotic off-label use significantly increased among patients with anxiety disorder in this national representative cohort. Such increased use of antipsychotics could be driven by augmentation of their prescription for major depression. As their efficacy and safety remain uncertain, further study is warranted.
    日期: 2019-08
    關聯: Psychiatry and Clinical Neurosciences. 2019 Aug;73(8):501-507.
    Link to: http://dx.doi.org/10.1111/pcn.12861
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1323-1316&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000478903200010
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85067349063
    显示于类别:[蔡慧如] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB31077503.pdf1249KbAdobe PDF342检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈